Research programme: KDR kinase inhibitors - WyethAlternative Names: KDR inhibitor 1 - Wyeth; KDR inhibitor 2 - Wyeth
Latest Information Update: 03 Oct 2011
At a glance
- Originator Wyeth
- Class Quinones
- Mechanism of Action Vascular endothelial growth factor receptor-2 antagonists
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 10 May 2005 Preclinical trials in Cancer in USA (unspecified route)